In vivo iontophoretic delivery of salmon calcitonin across microporated skin

Journal of Pharmaceutical Sciences

Volumn 101, Issue 8, 2012, Pages 2861-2869

  Vemulapalli, Viswatej ^a   Bai, Yun ^a   Kalluri, Haripriya ^a   Herwadkar, Anushree ^a   Kim, Hyun ^b   Davis, Shawn P ^b   Friden, Phil M ^b   Banga, Ajay K ^a  

^a MERCER UNIVERSITY   (United States)

^b Transport Pharmaceuticals   (United States)

Author keywords

Histology; HPLC; Iontophoresis; Microneedles; Osteoporosis; Peptide delivery; Pharmacokinetics; Salmon calcitonin; Skin; Transdermal drug delivery

Indexed keywords

MALTOSE; SALCATONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOLOGY; IN VIVO STUDY; IONTOPHORESIS; MALE; MEDICAL TECHNOLOGY; MICRONEEDLE; NEEDLE; NONHUMAN; OSTEOPOROSIS; PAGET BONE DISEASE; RAT; SCANNING ELECTRON MICROSCOPY; SKIN; SKIN PERMEABILITY;

EID: 84862902023     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23222     Document Type: Article

References (32)

1. Pergo C, Fabre M, Torres D, Alonso M. 2006. Efficacy and mechanism of action of chitosan nanocapsules for oral peptide delivery. Pharm Res 23:549-556.
2. Song KH, Chung SJ, Shim CK. 2005. Enhanced intestinal absorption of salmon calcitonin from proliposomes containing bile salts. J Control Release 106:298-308.
3. Basan H, Gümüşderelioǧlu M, Tevfik Orbey M. 2007. Release characteristics of salmon calcitonin from dextran hydrogels from colon-specific delivery. Eur J Pharm Biopharm 65:39-46.
4. Hee LY, Leesman GD, Makhey V, Yu H, Hu P, Perry B, Sutyak JP, Wagner EJ, Falzone LM, Steron M, Sinko PJ. 2000. Regional oral absorption, hepatic first-pass effect, and nonlinear disposition of salmon calcitonin in beagle dogs. Eur J Pharm Biopharm 50:205-211.
5. Torres-Lugo M, Peppas NA. 2000. Transmucosal delivery systems for calcitonin: A review. Biomaterials 21:1191-1196.
6. Barry BW. 2002. Drug delivery routes in skin: A novel approach. Adv Drug Deliv Rev 54:31-40.
7. Badkar AV, Smith AM, Epstein JA, Banga AK. 2007. Transdermal delivery of interferon alpha -2B using microporation and iontophoresis in hairless rats. Pharm Res 24:1389-1395.
8. Banga AK. 2011. Transdermal and intradermal delivery of therapeutic agents: Application of physical technologies. New York: CRC press, pp 1-285.
9. Prausnitz MR. 2004. Microneedles for transdermal drug delivery. Adv Drug Deli Rev 56:581-587.
10. Banga AK. 2009. Microporation applications for enhancing drug delivery. Expert Opin Drug Deliv 6:343-354.
11. Davis SP, Landis BJ, Adams ZH, Allen MJ, Prausnitz MR. 2004. Insertion of microneedles into skin: Measurement and prediction of insertion force and needle fracture force. J Bio Mech 37:1155-1163.
12. Li G, Badkar A, Nema S, Kolli CS, Banga AK. 2009. In vitro transdermal delivery of therapeutic antibodies using maltose microneedles. Int J Pharm 368:109-115.
13. Coulman SA, Barrow D, Anstey A, Gateley C, Morrissey A, Wilke N, Allender C, Brian K, Birchall JC. 2006. Minimally invasive cutaneous delivery of macromolecules and plasmid DNA via microneedles. Curr Drug Del 3:65-75.
14. Nakamura K, Katagai K, Mori K, Higo N, Sato S, Yamamoto K. 2001. Transdermal administration of salmon calcitonin by pulse depolarization-iontophoresis in rats. Int J Pharm 218:93-102.
15. Chaturvedula A, Joshi DP, Anderson C, Morris RL, Sembrowich WL, Banga AK. 2005. In vivo iontophoretic delivery and pharmacokinetics of salmon cacitonin. Int J Pharm 297:190-196.
16. Stamatialis DF, Rolevink HH, Koops GH. 2004. Passive and iontophoretic delivery of salmon calcitonin through artificial membranes. Curr Drug Deliv 1:137-143.
17. Thysman S, Hanchard C, Preat V. 1994. Human calcitonin delivery in rats by iontophoresis. J Pharm Pharmacol 46:725-730.
18. Chang SL, Hofmann GA, Zhang L, Deftos LJ, Banga AK. 2000. The effect of electroporation on iontophoretic transdermal delivery of calcium regulating hormones. J Control Release 66:127-133.
19. Vemulapalli V, Yang Y, Friden PM, Banga AK. 2008. Synergistic effect of iontophoresis and soluble microneedles for transdermal delivery of methotrexate. J Pharm Pharmacol 60:27-33.
20. Kolli CS, Banga AK. 2008. Characterization of solid maltose microneedles and their use for transdermal delivery. Pharm Res 25:104-113.
21. Singh P, Roberts MS, Maibach HI. 1995. Modeling of plasma levels of drugs following transdermal iontophoresis. J Control Release 33:293-298.
22. Karsdal MA, Byrjalsen I, Riis BJ, Christiansen C. 2008. Optimizing bioavailability of oral administration of small peptides through pharmacokinetic and pharmacodynamic parameters: The effect of water and timing of meal intake on oral delivery of salmon calcitonin. BMC Clin Pharmacol 8:5.
23. Miyano T, Tobinga Y, Kanno T, Matusuzaki Y, Takeda H, Wakui M, Hanada K. 2005. Sugar micro needles as transdermic drug delivery system. Biomed Microdevices 7:185-188.
24. Kalluri H, Banga AK. 2011. Formation and closure of microchannels in skin following microporation. Pharm Res 28:82-94.
25. Haq MI, Smith E, John DN, Kalavala M, Edwards C, Anstey A, Morrissey A, Birchall JC. 2009.Clinical administration of microneedles: Skin puncture, pain and sensation. Biomed Microdevices 11:35-47.
26. Santi P, Colombo P, Bettini R, Catellani PL, Minutello A, Volpato NM. 1997. Drug reservoir composition and transport of salmon calcitonin in transdermal iontophoresis. Pharm Res 14:63-66.
27. Chang SL, Hofmann GA, Zhang L, Deftos LJ, Banga AK. 2000. Transdermal iontophoretic delivery of salmon calcitonin. Int J Pharm 200:107-113.
28. Chang SL, Hofmann GA, Zhang L, Deftos LJ, Banga AK. 2003. Stability of a transdermal salmon calcitonin formulation. Drug Deliv 10:41-45.
29. Wu XM, Todo H, Sugibayashi K. 2007. Enhancement of skin permeation of high molecular compounds by a combination of microneedle pretreatment and iontophoresis. J Control Release 118:189-195.
30. Katikaneni S, Badkar A, Nema S, Banga AK. 2009. Molecular charge mediated transport of a 13 kD protein across microporated skin. Int J Pharm 378:93-100.
31. Abla N, Naik A, Guy RH, Kalia YN. 2005. Contributions of electromigration and electroosmosis to peptide iontophoresis across intact and impaired skin. J Control Release 108:319-330.
32. Accessed May 15, 2011, at: